Salud financiera de hoja de balance de Pediatrix Medical Group
Salud financiera controles de criterios 4/6
Pediatrix Medical Group tiene un patrimonio de accionistas total de $732.5M y una deuda total de $626.7M, lo que sitúa su ratio deuda-patrimonio en 85.6%. Sus activos y pasivos totales son $2.1B y $1.3B respectivamente. El BAIT de Pediatrix Medical Group es de $164.6M, por lo que su ratio de cobertura de intereses es de 4.6. Tiene efectivo e inversiones a corto plazo que ascienden a $220.5M.
Información clave
85.6%
Ratio deuda-patrimonio
US$626.72m
Deuda
| Ratio de cobertura de intereses | 4.6x |
| Efectivo | US$220.45m |
| Patrimonio | US$732.49m |
| Total pasivo | US$1.34b |
| Activos totales | US$2.08b |
Actualizaciones recientes sobre salud financiera
Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden
Oct 19
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Recent updates
Pediatrix Medical Group: The Business Is Turning
Nov 18Pediatrix Medical Group, Inc. (NYSE:MD) Shares Fly 27% But Investors Aren't Buying For Growth
Nov 06Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden
Oct 19We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)
Sep 28Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified
Aug 07Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($528.2M) de MD superan a sus pasivos a corto plazo ($373.1M).
Pasivo a largo plazo: Los activos a corto plazo ($528.2M) de MD no cubren sus pasivos a largo plazo ($971.3M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de MD (55.5%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de MD ha pasado de 131.1% a 85.6% en los últimos 5 años.
Cobertura de la deuda: La deuda de MD está bien cubierta por el flujo de caja operativo (22.8%).
Cobertura de intereses: Los pagos de intereses de la deuda de MD están bien cubiertos por el BAIT (4.6x cobertura).